RedHill Biopharma (RDHL) Research & Development (2012 - 2023)
RedHill Biopharma (RDHL) posted quarterly Research & Development of $1.2 million for Q2 2023, down 15.29% year-over-year from $1.5 million in Q2 2022, and up 15.04% quarter-over-quarter from $1.1 million in Q1 2023.
RedHill Biopharma (RDHL) Research & Development (2012 - 2023) Analysis & Trends
RedHill Biopharma (RDHL) has reported Research & Development for 12 consecutive years, with $1.2 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Research & Development fell 15.29% year-over-year to $1.2 million; the TTM figure through Jun 2023 stood at $5.1 million (down 68.71% YoY), while the FY2025 annual figure was $2.0 million, up 27.39% from the prior year.
- Research & Development advanced to $1.2 million in Q2 2023 per RDHL's latest filing, from $1.1 million in the prior quarter.
- Across five years, Research & Development topped out at $10.3 million in Q2 2021 and bottomed at $1.1 million in Q1 2023.
- Historically, Research & Development has averaged $4.1 million across 5 years, with a median of $3.1 million in 2020.
- Annual changes were most pronounced in 2021 — Research & Development soared 221.34% — and 2022, when it tumbled 85.75%.
- RedHill Biopharma's Research & Development stood at $2.3 million in 2019, then jumped by 171.92% to $6.2 million in 2020, then retreated by 5.19% to $5.9 million in 2021, then sank by 80.69% to $1.1 million in 2022, then grew by 10.06% to $1.2 million in 2023.
- Business Quant data shows RDHL's Research & Development at $1.2 million in Q2 2023, $1.1 million in Q1 2023, and $1.1 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.25 Mn |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 1.61 Mn |
| Jun 30, 2022 | 1.47 Mn |
| Mar 31, 2022 | 3.06 Mn |
| Dec 31, 2021 | 5.87 Mn |
| Sep 30, 2021 | 5.82 Mn |
| Jun 30, 2021 | 10.33 Mn |
| Mar 31, 2021 | 7.48 Mn |
| Dec 31, 2020 | 6.19 Mn |
| Sep 30, 2020 | 4.32 Mn |
| Jun 30, 2020 | 3.21 Mn |
| Mar 31, 2020 | 2.77 Mn |
| Dec 31, 2019 | 2.28 Mn |
| Sep 30, 2019 | 2.80 Mn |
| Jun 30, 2019 | 6.97 Mn |
| Mar 31, 2019 | 5.37 Mn |
| Dec 31, 2018 | 5.78 Mn |
| Sep 30, 2018 | 6.62 Mn |